DD151872A5 - Verfahren zur herstellung von 6,6'-methylen-bis-(2,2,4-trimethyl-1,2-dihydrochinolin)derivaten - Google Patents

Verfahren zur herstellung von 6,6'-methylen-bis-(2,2,4-trimethyl-1,2-dihydrochinolin)derivaten Download PDF

Info

Publication number
DD151872A5
DD151872A5 DD80222412A DD22241280A DD151872A5 DD 151872 A5 DD151872 A5 DD 151872A5 DD 80222412 A DD80222412 A DD 80222412A DD 22241280 A DD22241280 A DD 22241280A DD 151872 A5 DD151872 A5 DD 151872A5
Authority
DD
German Democratic Republic
Prior art keywords
dihydroquinoline
acid
trimethyl
methylene
sulfochloride
Prior art date
Application number
DD80222412A
Other languages
German (de)
English (en)
Inventor
Vilmos Baer
Original Assignee
Material Vegyipari Szoevetkeze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Material Vegyipari Szoevetkeze filed Critical Material Vegyipari Szoevetkeze
Publication of DD151872A5 publication Critical patent/DD151872A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
DD80222412A 1979-07-06 1980-07-04 Verfahren zur herstellung von 6,6'-methylen-bis-(2,2,4-trimethyl-1,2-dihydrochinolin)derivaten DD151872A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79MA3172A HU185208B (en) 1979-07-06 1979-07-06 Process for producing the water-soluble derivatives of 6,6-methylene-bis/2,2,4-trimetyl-1,2-dihidric quinoline/

Publications (1)

Publication Number Publication Date
DD151872A5 true DD151872A5 (de) 1981-11-11

Family

ID=10999106

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80222412A DD151872A5 (de) 1979-07-06 1980-07-04 Verfahren zur herstellung von 6,6'-methylen-bis-(2,2,4-trimethyl-1,2-dihydrochinolin)derivaten

Country Status (22)

Country Link
US (1) US4356306A (ko)
JP (2) JPS5639070A (ko)
AR (1) AR223884A1 (ko)
AT (1) AT375647B (ko)
BE (1) BE884187A (ko)
BR (1) BR8004170A (ko)
CA (1) CA1138873A (ko)
CH (1) CH649536A5 (ko)
CS (1) CS227309B2 (ko)
DD (1) DD151872A5 (ko)
DE (1) DE3025656A1 (ko)
DK (1) DK156436C (ko)
FI (1) FI75809C (ko)
FR (1) FR2460933B1 (ko)
GB (1) GB2054582B (ko)
HU (1) HU185208B (ko)
IT (1) IT1132511B (ko)
NL (1) NL8003839A (ko)
PL (2) PL126791B1 (ko)
SE (1) SE447899B (ko)
SU (2) SU990083A3 (ko)
YU (1) YU41933B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU200165B (en) * 1987-04-22 1990-04-28 Material Vegyipari Szoevetkeze Process for producing dihydroquinoline derivatives, as well as pharmaceutical compositions, fodders and fodder premixes comprising such compounds
US5292497A (en) * 1987-12-22 1994-03-08 U.S. Bioscience, Inc. Method of reducing chemotherapy toxicity using (methylaminopropylamino)propyl dihydrogen phosphorothioate
US5202338A (en) * 1990-10-31 1993-04-13 Vilmos Bar Dihydroquinoline derivatives, pharmaceutical compositions and methods of use of dihydroquinoline derivatives as modulators of the arachidonic acid cascade
DE10329860A1 (de) 2003-07-02 2005-01-20 Atto-Tec Gmbh Sulfonamidderivate polycyclischer Farbstoffe für analytische Anwendungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047521A (en) * 1959-08-13 1962-07-31 Monsanto Chemicals Method of making improved polymeric dihydroquinoline compositions
US4025631A (en) * 1971-09-07 1977-05-24 Material Ksz. Dihydroquinoline derivatives of antioxidant activity
US4046765A (en) * 1971-09-07 1977-09-06 Material Ksz. Dihydroquinoline derivatives of antioxidant activity and a process for the preparation thereof
BE788509A (fr) * 1971-09-07 1973-01-02 Material Vegyi Derives de dihydroquinoleine et procede de preparation

Also Published As

Publication number Publication date
PL232265A1 (ko) 1982-03-29
SU990083A3 (ru) 1983-01-15
YU41933B (en) 1988-02-29
JPS6225142B2 (ko) 1987-06-01
CH649536A5 (de) 1985-05-31
JPS62187457A (ja) 1987-08-15
DK156436C (da) 1990-01-22
US4356306A (en) 1982-10-26
DK156436B (da) 1989-08-21
YU174180A (en) 1983-09-30
FR2460933A1 (fr) 1981-01-30
HU185208B (en) 1984-12-28
FI75809C (fi) 1988-08-08
GB2054582A (en) 1981-02-18
PL126791B1 (en) 1983-08-31
GB2054582B (en) 1983-09-14
DE3025656A1 (de) 1981-01-22
PL125177B1 (en) 1983-04-30
ATA354480A (de) 1984-01-15
BR8004170A (pt) 1981-01-21
IT1132511B (it) 1986-07-02
SE8004973L (sv) 1981-01-07
CA1138873A (en) 1983-01-04
DK288080A (da) 1981-01-07
FR2460933B1 (fr) 1985-07-12
BE884187A (fr) 1980-11-03
IT8023268A0 (it) 1980-07-04
NL8003839A (nl) 1981-01-08
PL225476A1 (ko) 1981-11-27
FI802153A (fi) 1981-01-07
SU1108092A1 (ru) 1984-08-15
JPS6335622B2 (ko) 1988-07-15
JPS5639070A (en) 1981-04-14
DE3025656C2 (ko) 1989-06-22
SE447899B (sv) 1986-12-22
CS227309B2 (en) 1984-04-16
AR223884A1 (es) 1981-09-30
AT375647B (de) 1984-08-27
FI75809B (fi) 1988-04-29

Similar Documents

Publication Publication Date Title
DE3129750A1 (de) 5'-aminoalkyl-4',4,8-trialkylpsoralene
DE2634288A1 (de) Benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2718669C2 (ko)
DE3005580A1 (de) Guanidinobenzoesaeurederivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
DE69319590T2 (de) Melamine derivate zur verwendung in der behandlung von krebs
DE3033897C2 (ko)
DE68910211T2 (de) Estramustin-ester.
DE2707831C2 (de) 1-Nitro-9-Alkylaminoalkylaminoacridine, ihre Salze, Verfahren zur Herstellung dieser Verbindungen und ihre Verwendung
EP0044527A1 (de) Substituierte Adenosin-3',5'-phosphorsäurebenzyltriester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1470014A1 (de) Verfahren zur Herstellung von Derivaten der 2-Anilino-nikotinsaeure
CH644864A5 (de) Psoralenderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
DE2720545B2 (de) Derivate des 2,4-Diamino-6,7-dimethoxychinazolins, ihre Herstellung und pharmazeutische Mittel
DE1802162A1 (de) Neue N-Pyridylmethyliden-homocystein-thiolacton-Verbindung und Verfahren zu ihrer Herstellung
DD151872A5 (de) Verfahren zur herstellung von 6,6'-methylen-bis-(2,2,4-trimethyl-1,2-dihydrochinolin)derivaten
DE69318046T2 (de) Antikrebsbenzaldehydverbindungen
EP0190676A1 (de) All-cis-1,3,5-Triamino2,4,6-cyclohexantriol-Derivate, ihre Verwendung, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE1927759A1 (de) Neue basische Derivate des Benzoxazolin-2-ons und Verfahren zur Herstellung derselben
DE2618223C2 (ko)
DE2739443A1 (de) Dimere indol-dihydroindolcarboxamide, verfahren zu ihrer herstellung und ihre verwendung
DE1620177C3 (de) N-(2-Hydroxyäthyl)-piperazinocarboxymethyl-tetracyclin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1595870C3 (de) Verfahren zur Herstellung von 3-(o-Methoxyphenoxy)-1,2-propandiolnicotinaten und deren Säureadditionssalzen
US4510147A (en) Compositions for and medical use of water-soluble derivatives of 6,6-methylene-bis-(2,2,4-trimethyl-1,2-dihydroquinoline)
DE1802162C (de) N-(2-Methyl-3-hydroxy-5-hydroxymethyl-4-pyridylmethyliden)-homocysteinthiolacton, dessen Säureadditionssalze sowie Verfahren zu ihrer Herstellung
DE3203274A1 (de) Vitamin k(pfeil abwaerts)3(pfeil abwaerts)-(gamma)-cyclodextrin-einschlusskomplex, verfahren zu dessen herstellung und diesen einschlusskomplex enthaltende praeparate
DE2235400C3 (de) ^Chlor-S-sulfamoyl-anthranilsäuren, deren Salze, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende Arzneimittel